Dr. Martin Schmidhuber primarily advises clients in intellectual property matters. His particular expertise is in the area of trademark and labelling law. In cooperation with a worldwide network of law firms, his work focuses on the strategic management of national and international trademark portfolios and their legal representation (litigation). In addition, Martin Schmidhuber offers his clients, in particular companies from the life sciences, information technologies, E-commerce, food and beverages, and financial services sectors, comprehensive legal advice and assists them in such matters as conflict management and litigation as well as in product development and the drafting of contracts with a focus on licensing and R&D agreements. Martin Schmidhuber is heading RITTERSHAUS IP/IT practice group and lectures on trademark law at Mannheim University as well as at SRH University of Applied Sciences Heidelberg.
- Industrial property law, in particular trademark law
- Competition law and healthcare advertising law
- Copyright and IT law
- Commercial and general economic law
- Litigation
- 1996 - 1997 Law studies in Frankfurt/Main
- 1997 - 2001 Law studies in Heidelberg
- 2004 PhD (Dr. iur.) at Heidelberg University
- 2004/2005 Lawyer at a law firm in Boston (USA)
- 2005 Admitted to the German bar
- 2010 Partner of RITTERSHAUS law firm
- Lecturer at Mannheim University
- Lecturer at Heidelberg SRH University of Applied Sciences
- Member of the Deutsche Vereinigung für gewerblichen Rechtsschutz und Urheberrecht/GRUR (German Association for the Protection of Intellectual Property)
- Member of the Deutsch-Amerikanische-Juristen-Vereinigung (DAJV) (German-American Lawyers’ Association)
- Member of the Interdisziplinäre Zentrum für Geistiges Eigentum an der Universität Mannheim e. V. (IZG), (Interdisciplinary Centre of Intellectual Property at Mannheim University)
- Member of the LES Licensing Executives Society
- Member of the Internet Committee of the International Trademark Association (INTA)
- "Steht Ihr Flug noch zum Einsteigen bereit?“ – Anmerkungen zum fliegenden Gerichtsstand im UWG-Prozess (gemeinsam mit Henrik Steffen Becker), Zeitschrift für das Recht der digitalen Wirtschaft (ZdiW) 2022, 144 ff.
- "Preisunterschiede und Vertragsgestaltung als Indiz für Marktabschottung durch Vertriebssysteme", WRP 10/2021, S. 1271 (Koautor)
- "Zwischen "Natur-Aktien-Index" und myschwiegermutterkäse" - Überlegungen zur Vereinheitlichung der Prüfungspraxis absoluter Schutzhindernisse von Marken", WRP 11/2015, S. 1296 (Koautor)
- „Rücknahme und Neueinreichung des Verfügungsantrags - Ein rechtsmissbräuchliches Auslaufmodell?", WRP 4 /2013, S. 436 (Koautor)
- "Verhaltenskodizes im neuen UWG - Überlegungen zur Bedeutung für die lauterkeitsrechtliche Praxis in Deutschland", WRP 2010, S. 593
- „Die Serienmarke nach der BAINBRIDGE-Rechtsprechung“, WRP 2009, S. 545 (Koautor)
- „Schadensersatz bei falscher oder unvollständiger Erteilung einer Auskunft“, WRP 2008, S. 296
- „Verhaltenskodizes im nationalen und grenzüberschreitenden elektronischen Geschäftsverkehr“, 2004 (ISBN 978-3-6315-2733-7)
- „LUXOR und PAPYRUS“ (Lieferung einer Papiermaschine), Fallbesprechung in: Rittershaus/Teichmann, Anwaltliche Vertragsgestaltung - Methodische Anleitung zur Fallbearbeitung im Studium, 2003 (ISBN 978-3-8114-1823-3)
- Brexit - Deadline for late registration of trade mark and design applications in the UK expires on 30 September 2021!
- Brexit - Clarity at last for owners of EU-wide protected trademarks and designs - Blog post by Dr Martin Schmidhuber
- Brexit - Need for action for owners of EU-wide protected trade marks and designs? - Blog post by Dr Martin Schmidhuber
- Advising the Eichbaum private brewery on the sale of the KARAMALZ brand to Veltins
- Advising Heraeus Holding on the acquisition of shares in AI software company Smart Steel Technologies
- Advising DKFZ on technology transfer in transaction with Cullinan Oncology
- Advising Heidelberg Pharma on participation in German-French joint venture
- Advising the international stem cell therapy company Cytonet GmbH & Co. KG on the sale of its cell therapy technology, its product Heparesc and its US subsidiary to the Belgian biotech company Promethera Biosciences S.A. and the acquisition of shares in Promethera
- Advising SSP on the acquisition of 33 Heberer bakeries at high-frequency sites
- Advising SRH Holding on transaction of Mundanis Frankfurter Stadtschulen
- Advising of Losberger GmbH on the acquisition of GRAEFF